Terminal Illness
37
4
4
25
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.4%
2 terminated out of 37 trials
92.6%
+6.1% vs benchmark
8%
3 trials in Phase 3/4
8%
2 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (37)
Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Targeting Bias to Reduce Disparities in End of Life Care
Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations
Fever In Palliative Care
Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof
DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
Quality of Life of the Piloted Individuals and a Cost-efficiency Analysis
Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness
iLIVE Volunteer Study
Family Talk Intervention in the Context of Specialised Palliative Home Care
GAMification to Encourage End-Of-Life Discussions Between ICD Patients and Caregivers
Parenteral Nutrition Therapy in Patients With Incurable Cancer
'LIFEView' Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life
Comparing Haloperidol and Olanzapine in Treating Terminal Delirium
Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness
Participating in Palliative Care Research
ADJUST: A Study on MDT Prognostication
GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products